IgG-Switched CLL Has a Distinct Immunogenetic Signature from the Common MD Variant: Ontogenetic Implications

CLINICAL CANCER RESEARCH

Vardi, A; Agathangelidis, A; Sutton, LA; Chatzouli, M; Scarfo, L; Mansouri, L; Douka, V; Anagnostopoulos, A; Darzentas, N; Rosenquist, R; Ghia, P; Belessi, C; Stamatopoulos, K, 2014: IgG-Switched CLL Has a Distinct Immunogenetic Signature from the Common MD Variant: Ontogenetic Implications. CLINICAL CANCER RESEARCH 20(2), p. 323 - 330, doi: 10.1158/1078-0432.CCR-13-1993

Research Groups:

CEITEC authors: